Matthew de Jonge spent six years pursuing a deceptively simple observation: people wear glasses without hesitation, but hearing aids carry stigma that keeps millions from using them. That insight drove him to build Fortell, an AI-powered hearing aid startup that just closed a $163 million funding round led by Founders Fund, Thrive Capital, and Valor Equity Partners.
The round signals serious venture conviction around a massive market opportunity. Hearing loss affects over 1.5 billion people globally, yet adoption rates remain abysmal. The global hearing aid market sits around $10 billion annually, but that figure masks a penetration problem. Most people who need hearing aids don't wear them. The reasons range from social stigma to poor sound quality to prohibitive costs that force consumers through medical gatekeeping.
Fortell's approach targets that gap with direct-to-consumer AI hearing aids designed to feel more like consumer electronics than medical devices. The startup positions itself against incumbents like Phonak, Widex, and Starkey, which have dominated through hearing aid dispensers and audiologists for decades. Those legacy players charge $2,000 to $6,000 per pair. Fortell and competitors like Nuheara and Eargo have disrupted that model by going direct and leveraging AI to personalize sound profiles without requiring extensive audiologist visits.
De Jonge's six-year build before closing this round suggests the technical challenge runs deeper than most consumer hardware. Hearing aids require precise audio processing, battery efficiency, connectivity, and comfort for all-day wear. AI layers onto that by learning individual hearing patterns and ambient environments over time. The startup likely invested heavily in proprietary audio algorithms, mobile app integration, and the clinical validation needed to position hearing aids as wellness rather than medical devices.
Founders Fund's participation stands out. The fund has backed companies like Palantir and SpaceX by backing founders solving problems at scale. Thrive Capital's involvement signals confidence in consumer defensibility and unit economics. Both investors see hearing aids as a consumer category ripe for disruption, similar to how Warby Parker dismantled eyeglass retail gatekeeping.
Antonio Gracias joins as an individual investor. Gracias, an early Tesla investor and founder of Valor Equity, typically backs energy and industrial infrastructure plays. His presence here suggests Fortell carries his conviction around overlooked consumer health needs and manufacturing scale.
The $163 million round values the company and positions Fortell to expand its product line, scale marketing to build brand awareness, and likely enter international markets where hearing aid penetration lags even further behind the US. The startup will need that capital for clinical studies, FDA compliance work, and marketing spend to overcome decades of stigma around hearing aids.
The path forward involves converting non-users into active wearers. That requires ongoing product refinement, aggressive direct-to-consumer marketing, insurance partnerships, and possibly financing programs to remove price barriers. Fortell competes not just against legacy hearing aid makers but against user inertia itself. De Jonge's bet rests on the same insight that made glasses ubiquitous: if the device works well and looks good, people will wear it.